31.89
price up icon0.47%   0.15
after-market アフターアワーズ: 32.03 0.14 +0.44%
loading
前日終値:
$31.74
開ける:
$31.53
24時間の取引高:
2.62M
Relative Volume:
0.24
時価総額:
$36.59B
収益:
$16.88B
当期純損益:
$666.71M
株価収益率:
52.01
EPS:
0.6132
ネットキャッシュフロー:
$251.19M
1週間 パフォーマンス:
+5.07%
1か月 パフォーマンス:
+21.16%
6か月 パフォーマンス:
+92.57%
1年 パフォーマンス:
+40.98%
1日の値動き範囲:
Value
$31.47
$31.89
1週間の範囲:
Value
$30.50
$31.99
52週間の値動き範囲:
Value
$12.46
$31.99

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile

Name
名前
Teva Pharmaceutical Industries Ltd Adr
Name
セクター
Healthcare (1131)
Name
電話
972 (3) 914-8213
Name
住所
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Name
職員
35,686
Name
Twitter
@TevaUSA
Name
次回の収益日
2025-01-29
Name
最新のSEC提出書
Name
TEVA's Discussions on Twitter

TEVA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
31.89 36.41B 16.88B 666.71M 251.19M 0.6132
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
126.23 55.30B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.65 49.22B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.13 44.97B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
507.16 22.16B 3.08B 1.24B 1.07B 25.61

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-09 開始されました Barclays Overweight
2025-12-05 開始されました Scotiabank Sector Outperform
2025-06-06 開始されました Goldman Buy
2025-05-28 開始されました Truist Buy
2025-05-12 アップグレード JP Morgan Neutral → Overweight
2024-07-10 アップグレード Argus Hold → Buy
2024-03-08 アップグレード JP Morgan Underweight → Neutral
2024-02-12 アップグレード Piper Sandler Neutral → Overweight
2024-01-23 アップグレード Jefferies Hold → Buy
2024-01-03 アップグレード Piper Sandler Underweight → Neutral
2023-12-18 開始されました HSBC Securities Buy
2023-11-27 アップグレード UBS Neutral → Buy
2023-07-06 アップグレード UBS Sell → Neutral
2023-05-25 開始されました Morgan Stanley Equal-Weight
2023-05-18 アップグレード Evercore ISI In-line → Outperform
2023-01-19 ダウングレード Jefferies Buy → Hold
2022-11-14 ダウングレード JP Morgan Neutral → Underweight
2022-11-04 ダウングレード UBS Neutral → Sell
2022-10-21 再開されました Jefferies Buy
2022-08-05 アップグレード BofA Securities Neutral → Buy
2022-06-14 再開されました UBS Neutral
2022-05-17 アップグレード BofA Securities Underperform → Neutral
2022-05-04 ダウングレード Piper Sandler Neutral → Underweight
2022-04-05 アップグレード Barclays Equal Weight → Overweight
2022-03-25 アップグレード Bernstein Mkt Perform → Outperform
2022-01-27 ダウングレード Argus Buy → Hold
2021-10-28 ダウングレード Raymond James Outperform → Mkt Perform
2021-05-04 ダウングレード UBS Buy → Neutral
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2020-11-25 開始されました Oppenheimer Perform
2020-08-06 アップグレード Barclays Underweight → Equal Weight
2020-07-27 再開されました Goldman Neutral
2020-06-01 アップグレード SunTrust Hold → Buy
2020-04-24 再開されました Citigroup Neutral
2020-04-06 アップグレード UBS Neutral → Buy
2020-02-24 ダウングレード Edward Jones Hold → Sell
2019-11-12 アップグレード JP Morgan Underweight → Neutral
2019-10-17 アップグレード Gabelli & Co Hold → Buy
2019-08-07 ダウングレード Evercore ISI Outperform → In-line
2019-07-19 開始されました Wolfe Research Peer Perform
2019-07-15 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-07-10 再開されました Credit Suisse Neutral
2019-07-05 アップグレード Argus Hold → Buy
2019-06-11 開始されました Barclays Underweight
2019-06-03 アップグレード Oppenheimer Perform → Outperform
2019-05-30 ダウングレード BofA/Merrill Buy → Underperform
2019-05-28 ダウングレード UBS Buy → Neutral
2019-03-20 開始されました SunTrust Hold
2019-03-07 再開されました UBS Buy
すべてを表示

Teva Pharmaceutical Industries Ltd Adr (TEVA) 最新ニュース

pulisher
02:03 AM

Why a $34 Million Teva Stock Position Signals Confidence in a Long Repair Story - The Motley Fool

02:03 AM
pulisher
Dec 22, 2025

J&J Stock Trading Above 50- & 200-Day SMA for 6 Months: How to Play - Finviz

Dec 22, 2025
pulisher
Dec 19, 2025

Teva Pharma stock hits 52-week high at 30.45 USD - Investing.com India

Dec 19, 2025
pulisher
Dec 18, 2025

Teva (TEVA): Assessing Valuation After a 65% Three‑Month Share Price Surge - Sahm

Dec 18, 2025
pulisher
Dec 17, 2025

BofA Raises Teva Pharmaceuticals Industries Limited (TEVA) Target to $32 as Barclays Initiates Overweight - Finviz

Dec 17, 2025
pulisher
Dec 16, 2025

FOLD Shares Hit 52-Week High: Time to Buy, Sell or Hold the Stock? - Finviz

Dec 16, 2025
pulisher
Dec 14, 2025

Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? - Finviz

Dec 14, 2025
pulisher
Dec 14, 2025

Has Teva’s 80% One Year Surge Run Ahead of Its Fundamental Valuation in 2025? - Sahm

Dec 14, 2025
pulisher
Dec 13, 2025

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026 - Sahm

Dec 13, 2025
pulisher
Dec 12, 2025

Teva Releases Q4 2025 Aide Memoire - Sahm

Dec 12, 2025
pulisher
Dec 11, 2025

Teva (NYSE:TEVA) Valuation Check After New Schizophrenia Drug Filing and Growing Growth Optimism - Sahm

Dec 11, 2025
pulisher
Dec 11, 2025

Teva’s FDA Filing For Once-Monthly Schizophrenia Drug Might Change The Case For Investing In TEVA - Sahm

Dec 11, 2025
pulisher
Dec 11, 2025

Teva Pharma stock hits 52-week high at 29.81 USD By Investing.com - Investing.com Nigeria

Dec 11, 2025
pulisher
Dec 11, 2025

Teva Pharma stock hits 52-week high at 29.81 USD - Investing.com

Dec 11, 2025
pulisher
Dec 10, 2025

TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia - Finviz

Dec 10, 2025
pulisher
Dec 09, 2025

Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play - Finviz

Dec 09, 2025
pulisher
Dec 04, 2025

Teva (NYSE:TEVA) Valuation Check After Strong Q3, Margin Targets and Deleveraging Drive a Sharp Share Price Rebound - Sahm

Dec 04, 2025
pulisher
Dec 01, 2025

Teva Shares Rise Following Launch of First Generic GLP-1 Weight Loss Drug - MSN

Dec 01, 2025
pulisher
Nov 30, 2025

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks - Finviz

Nov 30, 2025
pulisher
Nov 28, 2025

Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December - Sahm

Nov 28, 2025
pulisher
Nov 27, 2025

Is the Market Bullish or Bearish on Teva Pharmaceutical Industries Ltd? - Sahm

Nov 27, 2025
pulisher
Nov 26, 2025

Teva stock hits 52-week high at 26.38 USD - Investing.com

Nov 26, 2025
pulisher
Nov 25, 2025

Teva Rise Innovation Platform Might Change The Case For Investing In Teva Pharmaceutical Industries (TEVA) - Sahm

Nov 25, 2025
pulisher
Nov 25, 2025

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva® - Sahm

Nov 25, 2025
pulisher
Nov 19, 2025

Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma's Biggest Challenges - Finviz

Nov 19, 2025
pulisher
Nov 17, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Shares: Cheap or Risky? - fostersleader.com

Nov 17, 2025
pulisher
Nov 14, 2025

ANI Pharmaceuticals Stock Surges 53% YTD: Time to Buy or Sell? - Finviz

Nov 14, 2025
pulisher
Nov 13, 2025

Teva Pharma stock hits 52-week high at $25.96 By Investing.com - Investing.com Nigeria

Nov 13, 2025
pulisher
Nov 13, 2025

Teva Pharma stock hits 52-week high at $25.96 - Investing.com

Nov 13, 2025
pulisher
Nov 11, 2025

Teva (NYSE:TEVA) Valuation: Assessing Upside After Positive Earnings and Updated Long-Term Growth Targets - Sahm

Nov 11, 2025
pulisher
Nov 08, 2025

Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year? - sharewise.com

Nov 08, 2025
pulisher
Nov 06, 2025

Teva Pharmaceutical ADR Clears Key Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily

Nov 06, 2025
pulisher
Nov 05, 2025

Why Teva Pharmaceutical Stock Rocked the Market Today - Finviz

Nov 05, 2025
pulisher
Nov 05, 2025

Teva Fires on All Cylinders as Innovation and Pipeline Support Growth and Cost-Controls Lift Margins - Morningstar

Nov 05, 2025
pulisher
Nov 05, 2025

Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook - Sahm

Nov 05, 2025
pulisher
Nov 05, 2025

Earnings call transcript: Teva beats Q3 2025 forecasts, stock surges - Investing.com

Nov 05, 2025
pulisher
Nov 05, 2025

Teva stock hits 52-week high at 23.07 USD - Investing.com

Nov 05, 2025
pulisher
Nov 05, 2025

Teva stock hits 52-week high at 23.07 USD By Investing.com - Investing.com Philippines

Nov 05, 2025
pulisher
Nov 02, 2025

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November - Sahm

Nov 02, 2025
pulisher
Nov 01, 2025

Earnings call transcript: Teva’s Q2 2025 shows steady growth, stock rises - Investing.com

Nov 01, 2025
pulisher
Oct 31, 2025

Teva Pharmaceutical ADR Shows Rising Price Performance With Jump To 81 RS Rating - Investor's Business Daily

Oct 31, 2025
pulisher
Oct 29, 2025

Teva Pharmaceutical Industries Ltd (TEVA) Stock Price, Trades & News - GuruFocus

Oct 29, 2025
pulisher
Oct 28, 2025

eBay Upgraded, Meta Platforms Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Oct 28, 2025

Teva Pharmaceutical Industries Ltd Adr (TEVA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_specialty_generic HLN
$10.13
price up icon 0.30%
drug_manufacturers_specialty_generic TAK
$15.65
price up icon 0.45%
$507.16
price down icon 1.45%
drug_manufacturers_specialty_generic ZTS
$126.23
price up icon 0.59%
$145.26
price down icon 1.14%
大文字化:     |  ボリューム (24 時間):